Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | ||||||
{[ item.p_purity ]} | {[ item.pr_size ]} | Inquiry |
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price) ]} |
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price) ]} | {[ item.pr_usastock ]} | in stock Inquiry - | {[ item.pr_chinastock ]} | {[ item.pr_remark ]} in stock Inquiry - | Login | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
CAS No. : | 331646-99-2 | MDL No. : | MFCD11499006 |
Formula : | C8H5BrN2O2 | Boiling Point : | No data available |
Linear Structure Formula : | - | InChI Key : | XAKSYDAOQDFHDD-UHFFFAOYSA-N |
M.W : | 241.04 | Pubchem ID : | 22457660 |
Synonyms : |
|
Signal Word: | Warning | Class: | |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | |
Hazard Statements: | H315-H319-H335 | Packing Group: | |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
60% | With trichlorophosphate; In N,N-dimethyl-formamide; at 130.0℃; for 12.0h; | To a mixture of 8-bromoquinazoline-2,4(lH,3H)-dione (12.1 g, 50 mmol, 1 eq.) in POCl3(130 mL) was added DMF (0.5 mL). The mixture was stirred at 130 C for 12 h, then cooled to r.t. and concentrated. The resulting residue was dissolved in EA (100 mL) and poured into ice-water with vigorous stirring. The organic phase was separated and washed with brine, dried over anhydrous Na2S04and concentrated. The resulting residue was purified via column chromatography (PE/EA==10: 1, v/v) to afford 8-bromo-2,4- dichloroquinazoline as a yellow solid (9.1 g, 60% yield). |
60% | With trichlorophosphate; In N,N-dimethyl-formamide; at 130.0℃; for 12.0h; | [0287] To a mixture of <strong>[331646-99-2]8-bromoquinazoline-2,4(1H,3H)-dione</strong> (12.1 g, 50 mmol, 1 eq.) in POC13 (130 mL) was added DMF (0.5 mL). The mixture was stirred at 130 C for 12 h, then cooled to r.t. and concentrated. The resulting residue was dissolved in EA (100 mL) and poured into ice-water with vigorous stirring. The organic phase was separated and washed with brine, dried over anhydrous Na2 SO4 and concentrated. The resulting residue was purified via column chromatography (PE/EA==10:1, v/v) to afford 8-bromo-2,4- dichloroquinazoline as a yellow solid (9.1 g, 60% yield). |
0.377 g | With trichlorophosphate; at 100.0℃; | Step B: Phosphorus(V) oxy chloride (4.8 mL, 51.86 mmol, 25.0 eq.) was slowly added to a flask containing 8-bromoquinazoline-2,4(lH,3H)-dione (0.500 g, 2.07 mmol, 1.0 eq.). The mixture was heated to 100 C and the progress of the reaction was monitored by TLC analysis (hexanes/EtOAc 2: 1 v/v). Upon complete consumption of the starting material, the reaction mixture was cooled to room temperature and transferred portionwise to an Erlenmeyer flask containing crushed ice with the aid of CH2CI2. The resulting mixture was stirred for 20 min and then extracted with CH2CI2. The organic phases were combined, washed with saturated aqueous NaHCCb (3x40 mL), brine, dried over Na2SC>4, and concentrated in vacuo. The crude solid was purified by silica gel chromatography to provide 8- bromo-2,4-dichloroquinazoline (0.377 g, 65% yield). XH NMR (400 MHz, CDC13) delta 8.29 (d, J= 7.6 Hz, 1H), 8.26 (d, J= 8.4 Hz, 1H), 7.60 (t, J= 8.1 Hz, 1H). MS (ESI) m/z = 275.00 (M+H)+. LCMS Ret time (UV 214/254): 1.511 min. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Ca. 100% | at 200.0℃; for 3.0h; | A mixture of 2-amino-3-bromobenzoic acid (10.8 g, 50 mmol, 1 eq.) and urea (15 g, 250 mmol, 5 eq.) was stirred at 200 C for 3 h, then cooled and poured into ice-water. The solid was collected by filtration, washed with H20 for three times, and dried in vacuo to afford 8-bromoquinazoline-2,4(l -dione as a yellow solid (12.1 g, ca.100% yield). |
100% | at 200.0℃; for 3.0h; | [0286] A mixture of 2-amino-3-bromobenzoic acid (10.8 g, 50 mmol, 1 eq.) and urea (15 g, 250 mmol, 5 eq.) was stirred at 200 C for 3 h, then cooled and poured into ice-water. The solid was collected by filtration, washed with H20 for three times and dried in vacuo to afford 8-bromoquinazoline-2,4(1H,3H)-dione as a yellow solid (12.1 g, quant. yield). |
at 100.0℃; for 21.0h; | Step A: A vial containing 2-amino-3-bromobenzoic acid (1.00 g, 4.63 mmol, 1.0 eq.) was heated to 160 C. Urea (2.78 g, 46.29 mmol, 10.0 eq.) was added in portions. After 12 h, more urea (2.78 g, 46.29 mmol, 10.0 eq.) was added in portions. The reaction mixture stirred for an additional 8 h. The mixture was then cooled to 100 C and water (20 mL) was added. The resulting suspension was stirred for 1 h at 100 C before being allowed to cool to room temperature. The light brown solid was then collected by filtration. The crude 8-bromoquinazoline-2,4(lH,3H)-dione was used without further purification (0.883 g, 79% yield). l NMR (400 MHz, (CD3)2SO) delta 10.76 (br s, 2H), 7.93 (d, J = 7.8 Hz, 2H), 7.13 (t, J = 7.8 Hz, 1H). MS (ESI) m/z = 241.10 (M+H)+. LCMS Ret time (UV 214/254): 0.866 min. |